慢性阻塞性肺疾病中的白细胞介素-33：寻找反应亚组 - Suppr | 超能文献

IL-33 in COPD: the hunt for responder subgroups.

作者信息

Singh Dave

机构信息

University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK.

出版信息

Lancet Respir Med. 2022 May;10(5):425-426. doi: 10.1016/S2213-2600(22)00005-4. Epub 2022 Mar 24.

DOI:10.1016/S2213-2600(22)00005-4

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

IL-33 in COPD: the hunt for responder subgroups.慢性阻塞性肺疾病中的白细胞介素-33：寻找反应亚组

Lancet Respir Med. 2022 May;10(5):425-426. doi: 10.1016/S2213-2600(22)00005-4. Epub 2022 Mar 24.

2

The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.稳定期非过敏性 COPD 患者气道嗜酸性粒细胞炎症与 IL-33 的关系。

Respir Res. 2018 Jun 1;19(1):108. doi: 10.1186/s12931-018-0807-y.

3

Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype.气道阻塞性疾病中痰液中的白细胞介素-25、白细胞介素-33和胸腺基质淋巴细胞生成素、白细胞介素-23和白细胞介素-36。嗜酸性粒细胞表型中白细胞介素-36水平降低。

Cytokine. 2021 Apr;140:155421. doi: 10.1016/j.cyto.2021.155421. Epub 2021 Jan 22.

4

COPD exacerbations: targeting IL-33 as a new therapy.慢性阻塞性肺疾病急性加重：将白细胞介素-33作为一种新的治疗靶点

Lancet Respir Med. 2021 Nov;9(11):1213-1214. doi: 10.1016/S2213-2600(21)00182-X. Epub 2021 Jul 21.

5

Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.诱导痰中的白细胞介素-18：与慢性阻塞性肺疾病肺功能的关系。

Respir Med. 2009 Jul;103(7):1056-62. doi: 10.1016/j.rmed.2009.01.011. Epub 2009 Feb 8.

6

Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.稳定期慢性阻塞性肺疾病患者血清和痰中白细胞介素（IL）-10、IL-17A 和 IL-22 的表达。

COPD. 2013 Aug;10(4):459-65. doi: 10.3109/15412555.2013.770456. Epub 2013 Mar 28.

7

Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者诱导痰及支气管黏膜中白细胞介素-13的表达并未增加。

Allergy. 2008 Sep;63(9):1239-43. doi: 10.1111/j.1398-9995.2008.01717.x.

8

Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.诱导痰中细胞因子与慢性阻塞性肺疾病严重程度的关联

Respir Med. 2006 May;100(5):846-54. doi: 10.1016/j.rmed.2005.08.022. Epub 2005 Oct 7.

9

Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.生物恶化簇显示哮喘和慢性阻塞性肺疾病具有重叠特征，其介质和微生物组特征也不同。

J Allergy Clin Immunol. 2018 Jun;141(6):2027-2036.e12. doi: 10.1016/j.jaci.2018.04.013. Epub 2018 Apr 28.

10

[Correlation analysis of serum secreted frizzled-related protein 5 levels with airway inflammation and insulin resistance in chronic obstructive pulmonary disease patients].慢性阻塞性肺疾病患者血清分泌型卷曲相关蛋白5水平与气道炎症及胰岛素抵抗的相关性分析

Zhonghua Jie He He Hu Xi Za Zhi. 2017 Dec 12;40(12):903-908. doi: 10.3760/cma.j.issn.1001-0939.2017.12.008.

引用本文的文献

1

A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4.一项评估IL-33单克隆抗体托扎单抗治疗慢性阻塞性肺疾病患者的2a期试验：FRONTIER-4。

Eur Respir J. 2025 Jul 14;66(1). doi: 10.1183/13993003.02231-2024. Print 2025 Jul.

2

Systemic Markers of Lung Function and Forced Expiratory Volume in 1 Second Decline across Diverse Cohorts.不同队列中肺功能的系统标志物和 1 秒用力呼气量的下降。

Ann Am Thorac Soc. 2023 Aug;20(8):1124-1135. doi: 10.1513/AnnalsATS.202210-857OC.